Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Bristol/Myers Squibb Co

Recent news which mentions Bristol/Myers Squibb Co

< Previous 1 2 3 4 Next >
Trump's drug price ultimatum sets pharma firms scrambling
Tags Trade Amgen Inc Sanofi SA
From CNBC.com News
Pandemic darlings Moderna, BioNTech are now on two different paths
Tags Biotech and Pharmaceuticals Moderna Inc Health care industry
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Roche Holding AG Novartis AG Novo Nordisk A/S
From CNBC.com News
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
Tags US: News Pharmaceuticals Bristol/Myers Squibb Co
From CNBC.com News
Cramer's Lightning Round: 'You can speculate with' CleanSpark
Tags S&P 500 Business News Market Outlook
From CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
Tags Gilead Sciences Inc Johnson & Johnson Bristol/Myers Squibb Co
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags Gilead Sciences Inc Pharmaceuticals US: News
From CNBC.com News
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Tags Social issues Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
Tags Healthy Returns Social issues Biotech and Pharmaceuticals
From CNBC.com News
Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know
Tags Bristol/Myers Squibb Co Pharmaceuticals US: News
From CNBC.com News
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
Tags Companies Health & Science Health care industry
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Centene Corp Bristol/Myers Squibb Co Elevance Health Inc
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Biotechnology Business News GSK plc
From CNBC.com News
Jim Cramer says investors should follow the post-dot-com-bubble playbook
Tags U/S/ Markets Stock markets Bristol/Myers Squibb Co
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Biotech and Pharmaceuticals AstraZeneca PLC LILLY DRN
From CNBC.com News
Cramer's Lightning Round: Deere is a buy
Tags Market Outlook Business News Business
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Novo Nordisk A/S Merck & Co Inc Breaking News: Business
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags NVIDIA Corp Ford Motor Co Economy
From CNBC.com News
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
Tags Bristol/Myers Squibb Co Breaking News: Earnings US: News
From CNBC.com News
5 things to know before the stock market opens Monday
Tags LILLY DRN General Motors Co Yum! Brands Inc
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Amazon/com Inc Business News Novo Nordisk A/S
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Theravance Biopharma Inc Pharmaceuticals Bristol/Myers Squibb Co
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Bristol/Myers Squibb Co Pharmaceuticals US: News
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Dexcom Inc Moderna Inc GSK plc
From CNBC.com News
Bristol Myers Squibb CEO describes new drug for treating schizophrenia
Tags Bristol/Myers Squibb Co Stock Picks Investment strategy
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Biotech and Pharmaceuticals Social issues Healthy Returns
From CNBC.com News
Here are our top 10 things to watch in the stock market Monday
Tags Nissan Motor Co Ltd Alphabet Inc CNBC Investing Club
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags GE HealthCare Technologies Inc Novo Nordisk A/S AstraZeneca PLC
From CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
Tags LILLY DRN Business News THE JM SMUCKDRN
From CNBC.com News
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Tags Bristol/Myers Squibb Co Breaking News: Earnings Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.